NFE2L2 and obesity disorder: Benzyl isothiocyanate (BITC) (31) (Table 2) attenuates obesity-induced hyperglycemia via the enhancement of Nrf2-mediated antioxidant IRS-1/AKT/TBC1D1 signaling in muscles [152].